TBPH vs WYNN · P/E 7.5, rev $38.4M vs P/E 29, rev $3.71B
Theravance Biopharma Inc (TBPH) versus Wynn Resorts Limited (WYNN) — a side-by-side from cached financials, not a winner call.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Wynn Resorts Limited (WYNN) is a resorts & casinos company listed on NASDAQ.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Latest reported WYNN revenue for 2026-06-30 was $3.71B. Net income was $260.5M. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
TBPH currently screens at market cap $861.5M and trailing P/E 7.5. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
Not investment advice. Open the TBPH and WYNN stock pages for the full models.
Not investment advice.